Boston Scientific Corp. insider trading
BSXfinancial statementsForm 4 filings on EDGAR366 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 2 insiders at Boston Scientific Corp. bought $207K of stock in the open market, and 0 sold $0. Officers and directors accounted for $207K of purchases and $0 of sales. The last reported transaction was an option exercise by O'Connor Padraig Andrew on September 2, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through September 3, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $207KSold $0Aug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
366 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | option exercise | 1,171 | $0.00 | — | 8,459 | Sep 3, 2026 |
| Sep 2, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | tax withholding | 567 | $48.37 | $27K | 7,892 | Sep 3, 2026 |
| Aug 25, 2026 | Morano Susan E | Director | open-market buy | 2,040 | $49.22 | $100K | 13,784 | Aug 26, 2026 |
| Aug 11, 2026 | Woodworth Emily | SVP, Global Controller and CAO | discretionaryindirect | 2,930 | $51.19 | $150K | 2,930 | Aug 12, 2026 |
| Aug 10, 2026 | Monson Jonathan | EVP and CFO | discretionaryindirect | 9,908 | $50.46 | $500K | 9,908 | Aug 11, 2026 |
| Aug 5, 2026 | Habiger David C | Director | open-market buy | 2,100 | $47.59 | $100K | 17,160 | Aug 7, 2026 |
| Aug 4, 2026 | Habiger David C | Director | open-market buy | 140 | $48.59 | $7K | 15,060 | Aug 5, 2026 |
| Aug 3, 2026 | Habiger David C | Director | open-market buy | 1,042 | $48.07 | $50K | 14,920 | Aug 5, 2026 |
| Aug 3, 2026 | Mahoney Michael F | Chairman, President & CEO, Director | open-market buy | 186,240 | $48.33 | $9M | 2M | Aug 5, 2026 |
| Aug 3, 2026 | Mahoney Michael F | Chairman, President & CEO, Director | discretionaryindirect | 22,119 | $48.43 | $1M | 22,119 | Aug 5, 2026 |
| Jul 31, 2026 | Ludwig Edward J | Director | open-market buy | 5,000 | $45.48 | $227K | 30,359 | Aug 3, 2026 |
| Jul 31, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | discretionaryindirect | 64,198 | $46.73 | $3M | 64,198 | Aug 3, 2026 |
| Jul 1, 2026 | Monson Jonathan | EVP and CFO | option exercise | 2,087 | $0.00 | — | 40,073 | Jul 2, 2026 |
| Jul 1, 2026 | Monson Jonathan | EVP and CFO | tax withholding | 1,010 | $43.06 | $43K | 39,063 | Jul 2, 2026 |
| May 28, 2026 | Mahoney Michael F | Chairman, President & CEO, Director | giftindirect | 386,755 | $0.00 | — | 0 | Jun 1, 2026 |
| May 20, 2026 | Pegus Cheryl | Director | open-market buy | 1,770 | $56.49 | $100K | 1,770 | May 21, 2026 |
| May 20, 2026 | Ludwig Edward J | Director | open-market buy | 3,580 | $56.68 | $203K | 25,359 | May 21, 2026 |
| May 20, 2026 | Habiger David C | Director | open-market buy | 2,250 | $55.92 | $126K | 13,878 | May 21, 2026 |
| May 19, 2026 | Habiger David C | Director | open-market buy | 2,200 | $56.95 | $125K | 11,628 | May 21, 2026 |
| May 7, 2026 | Zane Ellen M | Director | award | 3,800 | $0.00 | — | 27,934 | May 11, 2026 |
| May 7, 2026 | Wichmann David S | Director | award | 3,800 | $0.00 | — | 45,382 | May 11, 2026 |
| May 7, 2026 | Weber Christophe Pierre | Director | award | 1,767 | $0.00 | — | 2,646 | May 11, 2026 |
| May 7, 2026 | Weber Christophe Pierre | Director | award | 1,140 | $0.00 | — | 3,786 | May 11, 2026 |
| May 7, 2026 | Morano Susan E | Director | award | 3,800 | $0.00 | — | 10,463 | May 11, 2026 |
| May 7, 2026 | Morano Susan E | Director | award | 1,281 | $0.00 | — | 11,744 | May 11, 2026 |
| May 7, 2026 | Mega Jessica L | Director | award | 3,800 | $0.00 | — | 12,035 | May 11, 2026 |
| May 7, 2026 | Ludwig Edward J | Director | award | 3,800 | $0.00 | — | 21,779 | May 11, 2026 |
| May 7, 2026 | Habiger David C | Director | award | 3,800 | $0.00 | — | 9,428 | May 11, 2026 |
| May 2, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | option exercise | 1,802 | $0.00 | — | 7,896 | May 4, 2026 |
| May 2, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | tax withholding | 872 | $56.50 | $49K | 7,024 | May 4, 2026 |
| May 2, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | option exercise | 2,102 | $0.00 | — | 57,894 | May 4, 2026 |
| May 2, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | tax withholding | 1,007 | $56.50 | $57K | 56,887 | May 4, 2026 |
| Mar 2, 2026 | Morano Susan E | Director | award | 24 | $0.00 | — | 6,663 | Mar 4, 2026 |
| Mar 2, 2026 | Weber Christophe Pierre | Director | award | 556 | $0.00 | — | 556 | Mar 4, 2026 |
| Mar 2, 2026 | Weber Christophe Pierre | Director | award | 323 | $0.00 | — | 879 | Mar 4, 2026 |
| Mar 1, 2026 | Woodworth Emily | SVP, Global Controller and CAO | option exercise | 838 | $0.00 | — | 3,231 | Mar 3, 2026 |
| Mar 1, 2026 | Woodworth Emily | SVP, Global Controller and CAO | tax withholding | 372 | $76.85 | $29K | 2,859 | Mar 3, 2026 |
| Feb 19, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | discretionaryindirect | 6,851 | $75.76 | $519K | 20,205 | Feb 27, 2026 |
| Feb 16, 2026 | Woodworth Emily | SVP, Global Controller and CAO | option exercise | 637 | $0.00 | — | 2,676 | Feb 18, 2026 |
| Feb 16, 2026 | Woodworth Emily | SVP, Global Controller and CAO | tax withholding | 283 | $74.73 | $21K | 2,393 | Feb 18, 2026 |
| Feb 16, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | tax withholding | 291 | $74.73 | $22K | 17,302 | Feb 18, 2026 |
| Feb 16, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | option exercise | 990 | $0.00 | — | 17,593 | Feb 18, 2026 |
| Feb 16, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | tax withholding | 339 | $74.73 | $25K | 6,094 | Feb 18, 2026 |
| Feb 16, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | option exercise | 905 | $0.00 | — | 6,433 | Feb 18, 2026 |
| Feb 16, 2026 | Monson Jonathan | EVP and CFO | tax withholding | 440 | $74.73 | $33K | 37,986 | Feb 18, 2026 |
| Feb 16, 2026 | Monson Jonathan | EVP and CFO | option exercise | 990 | $0.00 | — | 38,426 | Feb 18, 2026 |
| Feb 16, 2026 | Mahoney Michael F | Chairman, President & CEO, Director | option exercise | 16,265 | $0.00 | — | 2M | Feb 18, 2026 |
| Feb 16, 2026 | Mahoney Michael F | Chairman, President & CEO, Director | tax withholding | 7,865 | $74.73 | $588K | 2M | Feb 18, 2026 |
| Feb 16, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | tax withholding | 1,806 | $74.73 | $135K | 213,907 | Feb 18, 2026 |
| Feb 16, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | option exercise | 3,960 | $0.00 | — | 215,713 | Feb 18, 2026 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Mahoney Michael F | Chairman, President & CEO, Director | Aug 3, 2026 | open-market buy | 2M | $9M (1) | $15M (2) | 2 of 2 |
| Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | Jul 31, 2026 | discretionary | 213,907 | — | $5M (3) | 3 of 3 |
| Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | May 2, 2026 | option exercise | 57,894 | — | $2M (1) | 1 of 1 |
| Zane Ellen M | Director | May 7, 2026 | award | 27,934 | — | $1M (1) | 1 of 1 |
| Ludwig Edward J | Director | Jul 31, 2026 | open-market buy | 30,359 | $430K (2) | — | — |
| Habiger David C | Director | Aug 5, 2026 | open-market buy | 17,160 | $408K (5) | — | — |
| Morano Susan E | Director | Aug 25, 2026 | open-market buy | 13,784 | $100K (1) | — | — |
| Pegus Cheryl | Director | May 20, 2026 | open-market buy | 1,770 | $100K (1) | — | — |
| Brown Vance R | EVP, GC and Corp. Secretary | Feb 16, 2026 | tax withholding | 54,244 | — | — | — |
| Woodworth Emily | SVP, Global Controller and CAO | Aug 11, 2026 | discretionary | 3,231 | — | — | — |
| Sorenson John Bradley | EVP, Global Operations | May 5, 2025 | open-market sale | 18,705 | — | — | — |
| O'Sullivan Miriam | SVP, Chief HR Officer | Feb 16, 2026 | tax withholding | 17,302 | — | — | — |
| Brennan Daniel J. | EVP and CFO | Feb 19, 2025 | option exercise | 251,151 | — | — | — |
| Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | Feb 25, 2025 | open-market sale | 25,766 | — | — | — |
| Monson Jonathan | EVP and CFO | Aug 10, 2026 | discretionary | 40,073 | — | — | — |
| O'Connor Padraig Andrew | EVP, Global Operations | Sep 2, 2026 | option exercise | 8,459 | — | — | — |
| Carruthers Wendy | EVP, Human Resources | Dec 2, 2024 | option exercise | 36,291 | — | — | — |
| Weber Christophe Pierre | Director | May 7, 2026 | award | 2,646 | — | — | — |
| Wichmann David S | Director | May 7, 2026 | award | 45,382 | — | — | — |
| Mega Jessica L | Director | May 7, 2026 | award | 12,035 | — | — | — |
| Fujimori Yoshiaki | Director | Jul 29, 2025 | open-market sale | 2,081 | — | — | — |
| Sununu John E | Director | May 8, 2025 | award | 54,723 | — | — | — |
Questions
Are Boston Scientific Corp. insiders buying or selling?
Over the twelve months to November 1, 2026, 4 insiders at Boston Scientific Corp. sold $23M of stock in the open market, all by officers and directors, and 5 insiders bought $10M, all by officers and directors. Net, insiders sold $13M. Only open-market purchases and sales are counted.
Who sold the most Boston Scientific Corp. stock in the last year?
Mahoney Michael F (Chairman, President & CEO, Director) sold $15M in 2 open-market sales over the twelve months to November 1, 2026.
Do Boston Scientific Corp. executives sell under 10b5-1 plans?
7 of the 7 open-market sales in the last twelve months (100%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Boston Scientific Corp.
- Boston Scientific Corp. financial statements
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.